Edward Hogan to Cysteine Proteinase Inhibitors
This is a "connection" page, showing publications Edward Hogan has written about Cysteine Proteinase Inhibitors.
Connection Strength
0.322
-
Role of calpain and its inhibitors in tissue degeneration and neuroprotection in spinal cord injury. Ann N Y Acad Sci. 1997 Oct 15; 825:120-7.
Score: 0.138
-
Increased calpain expression is associated with apoptosis in rat spinal cord injury: calpain inhibitor provides neuroprotection. Neurochem Res. 2000 Oct; 25(9-10):1191-8.
Score: 0.042
-
E-64-d prevents both calpain upregulation and apoptosis in the lesion and penumbra following spinal cord injury in rats. Brain Res. 2000 Jun 09; 867(1-2):80-9.
Score: 0.041
-
Calpeptin and methylprednisolone inhibit apoptosis in rat spinal cord injury. Ann N Y Acad Sci. 1999; 890:261-9.
Score: 0.037
-
Neuron-microglia interaction induced bi-directional cytotoxicity associated with calpain activation. J Neurochem. 2016 11; 139(3):440-455.
Score: 0.032
-
Calpain in the pathophysiology of spinal cord injury: neuroprotection with calpain inhibitors. Brain Res Brain Res Rev. 2003 May; 42(2):169-85.
Score: 0.013
-
Diverse stimuli induce calpain overexpression and apoptosis in C6 glioma cells. Brain Res. 1999 May 22; 829(1-2):18-27.
Score: 0.010
-
New inhibitors of calpain prevent degradation of cytoskeletal and myelin proteins in spinal cord in vitro. J Neurosci Res. 1998 Jan 15; 51(2):218-22.
Score: 0.009